CompletedNCT07150078
Official study titleInvestigation of Differences in Dual and Single Motor and Cognitive Tasks of Children With Attention Deficit and Hyperactivity Disorder Compared to Healthy Children
This study has finished and is no longer accepting participants.
In ŞehitkamilADHDObservational studyAges 7–14
- Countries
- Türkiye
- Sponsor
- Gaziantep Islam Science and Technology University
CompletedNCT00025779
Official study titleMethylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesADHDMedication studyAges 5–14
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
TerminatedEUCTR 2008-003285-26
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyADHDHistorical research record
- Countries
- Germany
- Sponsor
- Universität Mainz, Klinik und Poliklinik für Kinder- und Jugendpsychiatrie und -psychotherapie
CompletedEUCTR 2013-002720-16
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SwedenADHDHistorical research record
- Countries
- Sweden
- Sponsor
- Stockholms Läns Sjukvårdsområde (SLSO)
CompletedEUCTR 2013-005017-12
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In NetherlandsADHDHistorical research record
- Countries
- Netherlands
- Sponsor
- Parnassia Bavo Groep - PsyQ
CompletedEUCTR 2012-000320-18
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In NetherlandsADHDHistorical research record
- Countries
- Netherlands
- Sponsor
- Parnassia Bavo Groep - PsyQ
CompletedEUCTR 2004-003853-13
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SwedenADHDHistorical research record
- Countries
- Sweden
- Sponsor
- Hela Pharma AB
CompletedEUCTR 2012-004298-20
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SwedenADHDHistorical research record
- Countries
- Sweden
- Sponsor
- Stockholm Centre for Dependency Disorders
Recruitment unclearEUCTR 2005-001909-25
Current recruitment status is unconfirmed.
This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.
In NorwayADHDHistorical research record
- Countries
- Norway
- Sponsor
CompletedNCT07314333
Official study titleA Phase 1, Single Blind, Parallel-arm Trial to Assess the Potential for Pharmacodynamic Interaction of Centanafadine When Co-administered With Stimulants in Healthy Adults
This study has finished and is no longer accepting participants.
In Salt Lake CityADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT07591896
Official study titleAdding VR-Based Episodic Future Thinking Training to Executive- Function Training for Children With ADHD: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In JinanADHDBehavioural studyAges 5–12
- Countries
- China
- Sponsor
- Qilu Hospital of Shandong University
CompletedNCT00190957
Official study titleAtomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse: A Randomized, Placebo-Controlled Trial
This study has finished and is no longer accepting participants.
Multiple locations, including El CentroADHDMedication studyAges 18+
- Countries
- United States, Canada
- Sponsor
- Eli Lilly and Company